To further expand its capabilities in Australia and the Asia-Pacific market, Canopy Growth launched Spectrum Therapeutics in Australia. The company will invest up to $16 million AUD (~$16 Million CAD) in the state of Victoria over the next four years to establish the Company’s Asia-Pacific (APAC) headquarters. Spectrum Therapeutics is working in partnership with the Victoria State Government to enable domestic cultivation and production of high-quality medical cannabis for patients in Australia, while serving as a distribution hub for other jurisdictions in the APAC. The new facility will operate as the APAC Research and Development centre and support ongoing research collaboration between Spectrum Therapeutics and Agriculture Victoria on innovations in medical cannabis cultivation and production. The Company began medical sales in Australia in May 2019 and intends to support Australian patients through imports until it’s domestic facilities are fully operational. Working alongside AusCann Group Holdings, a long-time Canopy partner and Australian-based medical cannabis company, Spectrum Therapeutics main priority is to improve the lives of cannabis patients.